Tech Company Financing Transactions

Neuronyx Funding Round

On 3/31/2009, Neuronyx announced $3.7 million in funding from Alliance Technology Ventures, Safeguard Scientifics and SCP Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

1 Great Valley Parkway 12
Malvern, PA 19355
USA

Phone

(610) 240-4150

Website

www.garnetbio.com

Email Address

[email protected]

Overview

Neuronyx has taken a deliberate commercial approach to the use of cellular therapies initially focused on ischemic diseases.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gerri Henwood

        

Chief Financial Officer

Joel Sussman

        

Vice President

Gene Kopen

        

Browse more venture capital transactions:

Prev: 3/31/2009: Xpressdocs venture capital transaction
Next: 3/31/2009: Global Value Commerce venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary